Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)

South Korea · Delayed Price · Currency is KRW

1,495.00

-60.00 (-3.86%)

Last updated: Aug 21, 2026, 3:00 PM KST

KRX:002210 Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Dec '11 Dec 31, 2011	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007
Revenue	78,442	78,442	71,926	68,724	62,231	60,319
Revenue Growth	13.99%	9.06%	4.66%	10.43%	3.17%	-4.15%
Gross Profit	45,211	45,211	39,884	41,003	36,722	36,393
Operating Income	3,104	3,104	-3,109	1,105	1,486	1,556
Net Income	1,701	1,701	-7,855	568.43	3,657	2,656
Earnings Per Share	96.34	96.34	-436.00	31.30	201.38	152.69
EPS Growth	-	-	-	-84.45%	31.89%	1.52%

Revenue by Segment

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009
Period Ending	Dec '11 Dec 31, 2011	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Medical Supply Business	68,562	68,562	62,519	60,083
Cosmetics Business	9,880	9,880	9,407	8,641
Total	78,442	78,442	71,926	68,724

Cash & Debt

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Dec '11 Dec 31, 2011	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007
Cash & Investments	14,246	14,246	18,120	12,791	13,589	13,703
Total Debt	34,930	34,930	33,677	31,305	27,037	31,381
Net Cash (Debt)	-20,685	-20,685	-15,557	-18,514	-13,448	-17,678
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1171.40	-1171.40	-863.57	-1019.60	-740.63	-1016.30

Cash Flow & CapEx

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Dec '11 Dec 31, 2011	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007
Operating Cash Flow	-2,643	-2,643	3,685	-5,021	-365.26	2,917
Capital Expenditures	-380.7	-380.7	-847.33	-721.58	-417.02	-1,715
Free Cash Flow	-3,024	-3,024	2,837	-5,743	-782.29	1,202
Free Cash Flow Growth	-	-	-	-	-	-51.90%

Margins

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Dec '11 Dec 31, 2011	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007
Gross Margin	57.64%	57.64%	55.45%	59.66%	59.01%	60.33%
Operating Margin	3.96%	3.96%	-4.32%	1.61%	2.39%	2.58%
Pretax Margin	2.23%	2.23%	-6.88%	0.98%	8.41%	5.76%
Profit Margin	2.17%	2.17%	-10.92%	0.83%	5.88%	4.40%
FCF Margin	-3.85%	-3.85%	3.94%	-8.36%	-1.26%	1.99%

Valuation

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Aug '26 Aug 24, 2026	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007
PE Ratio	15.52	14.48	-	46.16	5.97	13.74
P/FCF Ratio	-	-	8.74	-	-	30.36
PS Ratio	1.79	0.31	0.35	0.38	0.35	0.61